BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20225995)

  • 21. Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population.
    Stephenson JJ; Quimbo RA; Gutierrez B
    Am J Manag Care; 2010 Feb; 16(2):108-14. PubMed ID: 20148615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct costs of blindness experienced by patients enrolled in managed care.
    Frick KD; Walt JG; Chiang TH; Doyle JJ; Stern LS; Katz LM; Dolgitser M; Hendlish SK
    Ophthalmology; 2008 Jan; 115(1):11-7. PubMed ID: 17475331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
    Shah M; Butler M; Bramley T; Curtice TG; Fine S
    Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products.
    Bullano MF; Al-Zakwani IS; Fisher MD; Menditto L; Willey VJ
    Curr Med Res Opin; 2005 Feb; 21(2):291-8. PubMed ID: 15802000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of severe flexion deficits following total knee arthroplasty: a randomized clinical trial.
    Papotto BA; Mills T
    Orthop Nurs; 2012; 31(1):29-34. PubMed ID: 22278649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knee arthrofibrosis: prevention and management of a potentially devastating condition.
    Eakin CL
    Phys Sportsmed; 2001 Mar; 29(3):31-42. PubMed ID: 20086565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empty calories? A fragment on LIS white papers and the political sociology of LIS elites.
    Buschman J
    ; 2020 Sep; 46(5):102215. PubMed ID: 34170985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to 'Identification of novel biomarkers for arthrofibrosis after total knee arthroplasty in animal models and clinical patients'.
    Chen X; Wang Z; Huang Y; Deng W; Zhou Y; Chu M
    EBioMedicine; 2021 Sep; 71():103543. PubMed ID: 34419927
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: The attributable risk of smoking on surgical complications.
    Babayan RK
    J Urol; 2012 Jul; 188(1):182. PubMed ID: 22682850
    [No Abstract]   [Full Text] [Related]  

  • 34. New device - a knee probe.
    Frazier CH
    Orthopedics; 1981 Jan; 4(1):81. PubMed ID: 24822618
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: "TRASER: An innovative device for the treatment of nasal telangiectasias," lasers in surgery and medicine, 2017;49(6):625-631.
    Lasers Surg Med; 2017 Oct; 49(8):787. PubMed ID: 28921617
    [No Abstract]   [Full Text] [Related]  

  • 36. The efficacy of vitamin E in preventing arthrofibrosis after joint replacement.
    Fan Y; Yuh J; Lekkala S; Asik MD; Thomson A; McCanne M; Randolph MA; Chen AF; Oral E
    Animal Model Exp Med; 2024 Apr; 7(2):145-155. PubMed ID: 38525803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arthrofibrosis of the hip joint : Diagnostic and therapeutic challenge].
    Linke P; Lausmann C; Gehrke T; Citak M
    Unfallchirurgie (Heidelb); 2022 Nov; 125(11):868-871. PubMed ID: 35994058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of non-operative treatment of patients with knee arthrofibrosis using high-intensity home mechanical therapy: a retrospective review of 11,000+ patients.
    Stinton SK; Beckley SJ; Branch TP
    J Orthop Surg Res; 2022 Jul; 17(1):337. PubMed ID: 35794671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis.
    Trousdale WH; Limberg AK; Reina N; Salib CG; Thaler R; Dudakovic A; Berry DJ; Morrey ME; Sanchez-Sotelo J; van Wijnen A; Abdel MP
    Bone Joint Res; 2022 Jan; 11(1):32-39. PubMed ID: 35084209
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.